Cudarolimab, CAS 2244739-29-3

Product Description: Cudarolimab (IBI101) is a completely human anti-OX40 (CD134, a co stimulating molecule expressed by activated immune cells) antibody. Cudarolimab inhibits the binding of OX40 to its ligand OX40L. Cudarolimab has antitumor activity and can be used in cancer related research[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Kuang Z, et al. Development and characterization of a novel anti-OX40 antibody for potent immune activation. Cancer Immunol Immunother. 2020 Jun;69(6):939-950.

CAS Number: 2244739-29-3

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Cancer; Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Orexin Receptor (OX Receptor)

• Artikelnummer: MEXHY-P99836-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99836-10
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated